LeadIQ logo
Learn more at LeadIQ.com

Insights

Expanded R&D Portfolio FibroGen has recently expanded its research and development portfolio to include product candidates in the immuno-oncology and autoimmune space. This expansion presents an opportunity for collaborations and partnerships with companies specializing in these therapeutic areas.

Key Personnel Changes The appointment of new key personnel like the Senior Vice President & Chief Medical Officer presents an opportunity for networking and potential business discussions. Engaging with the leadership team could lead to exploring avenues for strategic partnerships or sponsorships.

Technology Stack Insight FibroGen utilizes a tech stack that includes Google Analytics, SAP S/4HANA, and New Relic among others. Leveraging these technologies allows for data-driven decision-making and potentially tailoring sales pitches towards a tech-savvy audience.

Financial Stability With a revenue ranging between $50M - $100M, FibroGen exhibits financial stability. This financial health can indicate a potential for investment opportunities or long-term partnerships with a company positioned for growth.

Competitive Positioning In comparison to similar companies like Vertex Pharmaceuticals and Eli Lilly, FibroGen's focus on biotechnology research could present a niche sales opportunity. Understanding the competitive landscape and highlighting unique selling propositions to potential clients can be advantageous.

Similar companies to FibroGen, Inc.

FibroGen, Inc. Tech Stack

FibroGen, Inc. uses 8 technology products and services including Google Analytics, Informatica, SAP S/4HANA, and more. Explore FibroGen, Inc.'s tech stack below.

  • Google Analytics
    Analytics
  • Informatica
    Enterprise
  • SAP S/4HANA
    Enterprise Resource Planning
  • jQuery
    Javascript Libraries
  • Polyfill
    Javascript Libraries
  • Boomi
    Platform As A Service
  • New Relic
    Real User Monitoring
  • Adobe Creative Suite
    Visualisation Software

Media & News

FibroGen, Inc.'s Email Address Formats

FibroGen, Inc. uses at least 1 format(s):
FibroGen, Inc. Email FormatsExamplePercentage
FLast@fibrogen.comJDoe@fibrogen.com
89%
FirstLast@fibrogen.comJohnDoe@fibrogen.com
7%
FiLast@fibrogen.comJoDoe@fibrogen.com
3%
FirLast@fibrogen.comJohDoe@fibrogen.com
1%

Frequently Asked Questions

Where is FibroGen, Inc.'s headquarters located?

Minus sign iconPlus sign icon
FibroGen, Inc.'s main headquarters is located at 409 Illinois St San Francisco, CA 94158 US. The company has employees across 5 continents, including North AmericaAsiaEurope.

What is FibroGen, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact FibroGen, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is FibroGen, Inc.'s stock symbol?

Minus sign iconPlus sign icon
FibroGen, Inc. is a publicly traded company; the company's stock symbol is FGEN.

What is FibroGen, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
FibroGen, Inc.'s official website is fibrogen.com and has social profiles on LinkedIn.

How much revenue does FibroGen, Inc. generate?

Minus sign iconPlus sign icon
As of August 2024, FibroGen, Inc.'s annual revenue reached $75M.

What is FibroGen, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
FibroGen, Inc.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does FibroGen, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2024, FibroGen, Inc. has approximately 415 employees across 5 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: T. W.Chief Executive Officer: E. C.Chief Financial Officer: J. G.. Explore FibroGen, Inc.'s employee directory with LeadIQ.

What industry does FibroGen, Inc. belong to?

Minus sign iconPlus sign icon
FibroGen, Inc. operates in the Biotechnology Research industry.

What technology does FibroGen, Inc. use?

Minus sign iconPlus sign icon
FibroGen, Inc.'s tech stack includes Google AnalyticsInformaticaSAP S/4HANAjQueryPolyfillBoomiNew RelicAdobe Creative Suite.

What is FibroGen, Inc.'s email format?

Minus sign iconPlus sign icon
FibroGen, Inc.'s email format typically follows the pattern of . Find more FibroGen, Inc. email formats with LeadIQ.

When was FibroGen, Inc. founded?

Minus sign iconPlus sign icon
FibroGen, Inc. was founded in 1993.
FibroGen, Inc.

FibroGen, Inc.

Biotechnology ResearchCalifornia, United States201-500 Employees

We are committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics to change the lives of people globally. We are also committed to being a place where our people and science thrive. 

Using our pioneering expertise in connective tissue growth factor (CGTF) and hypoxia-inducible factor (HIF) biology and clinical development, we hope to make a difference for people with unmet medical needs, including anemia, fibrotic disease and cancer. 

Pamrevlumab, an anti-CTGF human monoclonal antibody, is currently in clinical development for the treatment of locally advanced unresectable pancreatic cancer, and Duchenne muscular dystrophy. Roxadustat, an oral medication, is the first in a new class of medicines comprising HIF-PH inhibitors and is approved in China, Europe, Japan, and numerous other countries for the treatment of anemia of chronic kidney disease.  We have recently expanded our research and development portfolio to include product candidates in the immuno-oncology and autoimmune space.

Want to learn more? Visit https://www.fibrogen.com/our-culture. 

Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved FibroGen positions are only accessible via the FibroGen Careers page at www.fibrogen.com/careers.

Section iconCompany Overview

Headquarters
409 Illinois St San Francisco, CA 94158 US
Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
FGEN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1993
Employees
201-500

Section iconFunding & Financials

  • $50M$100M

    FibroGen, Inc.'s revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    FibroGen, Inc.'s revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.